Millennium Management’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,679
Closed -$249K 6390
2025
Q4
$249K Buy
35,679
+67
+0.2% +$375 ﹤0.01% 5361
2025
Q3
$166K Buy
35,612
+5,359
+18% +$25.1K ﹤0.01% 5597
2025
Q2
$165K Sell
30,253
-103,127
-77% -$553K ﹤0.01% 5425
2025
Q1
$736K Buy
133,380
+52,842
+66% +$281K ﹤0.01% 4575
2024
Q4
$403K Sell
80,538
-17,350
-18% -$73.3K ﹤0.01% 4896
2024
Q3
$451K Sell
97,888
-25,016
-20% -$132K ﹤0.01% 4911
2024
Q2
$678K Buy
122,904
+105,208
+595% +$892K ﹤0.01% 4395
2024
Q1
$173K Buy
+17,696
New +$163K ﹤0.01% 5423
2022
Q4
Sell
-166,908
Closed -$1.66M 7057
2022
Q3
$1.66M Sell
166,908
-355,733
-68% -$3.52M ﹤0.01% 3917
2022
Q2
$5.14M Sell
522,641
-143,055
-21% -$1.41M ﹤0.01% 2778
2022
Q1
$6.52M Buy
665,696
+491,086
+281% +$4.85M ﹤0.01% 2641
2021
Q4
$1.73M Sell
174,610
-11,250
-6% -$112K ﹤0.01% 3909
2021
Q3
$1.85M Buy
185,860
+154,998
+502% +$1.52M ﹤0.01% 4022
2021
Q2
$299K Buy
+30,862
New +$303K ﹤0.01% 5727

Other funds holding TLSI

Millennium Management's TLSI Position: Q1 2026 in Review

Millennium Management sold out of TriSalus Life Sciences (TLSI) in Q1 2026, closing a stake of 35,679 shares — an estimated $249K sold.

Millennium Management first reported a position in TLSI in Q2 2021 and held it in 14 quarters. The position peaked at $6.52M in Q1 2022. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Millennium Management reported no remaining TriSalus Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 35,679 TriSalus Life Sciences shares in Q1 2026, an estimated $249K.
  • Millennium Management first reported a position in TriSalus Life Sciences in Q2 2021 and held it in 14 quarters.
  • Millennium Management's TriSalus Life Sciences position peaked at $6.52M in Q1 2022.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.